Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387268308> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W4387268308 abstract "Abstract Objective To evaluate the clinical efficacy of peeling with a microemulsion formulation containing 1% retinoic acid. Materials and Methods After development of the product, 60 patients with melasma were randomly divided into three groups ( n = 20): Group 1–application of conventional 1% retinoic acid peeling (RA 1%). Group 2–application of 1% retinoic acid peeling in microemulsion (RA 1%M). Group 3–Application of placebo. The groups were submitted to four peeling sessions, fortnightly on Days 0, 15, 30, and 45, and analyzed at the time intervals of 0, 15, 30, 45, and 60 days. Evaluation was made by using the Melasma Area and Severity Index (MASI) and Melasma Quality of Life (MelasquoL) instrument. Hemato‐biochemical parameters were also evaluated at Days 0 and 60. After obtaining the results, normality was evaluated by means of the Kolmogorov–Smirnov test and afterwards, the following tests were applied: Friedman statistical (to test the effect of the treatments on the MASI index); Wilcoxon, (for comparison between pairs to test the effect of treatments on the MelasQoL index); Kruskal–Wallis, (to test the differences between the groups); and Mann–Whitney, (comparisons between treatments). The level of significance adopted was 5% (α = 0.05). Results The three groups presented a significant reduction in the MASI index, indicating the effect of all the treatments on reducing the melasma ( p < 0.001). A significant reduction in the stains was observed with the use of retinoic acid peeling delivered in microemulsion (62%) when compared with the conventional peeling with 1% retinoic acid in a conventional vehicle (26%) and the placebo (12%). There was also a significant reduction in the MelasQoL index (sum of all the aspects) in the three groups, indicating the effect of all the treatments, including the placebo, on the overall quality of life of those with melasma. However, RA 1%M the treatment that promoted the greatest effect on the quality of life of individuals. In percentage terms, the RA 1%M provided a mean reduction of 30% in the MelasQoL index, against 13% of the conventional treatment and only 4% of the placebo. When the hemato‐biochemical parameters were compared on Days 0 and 60, there were no significant changes in the results. Conclusion The chemical peeling performed with RA 1%M was effective for the treatment of melasma, and was shown to be superior to the peeling performed with retinoic acid in a conventional vehicle, in reducing the stains and improving the quality of life of patients." @default.
- W4387268308 created "2023-10-03" @default.
- W4387268308 creator A5002488034 @default.
- W4387268308 creator A5066020832 @default.
- W4387268308 creator A5072508737 @default.
- W4387268308 creator A5082184108 @default.
- W4387268308 date "2023-10-02" @default.
- W4387268308 modified "2023-10-17" @default.
- W4387268308 title "Peeling with retinoic acid in microemulsion for treatment of melasma: A double‐blind randomized controlled clinical study" @default.
- W4387268308 cites W1530245332 @default.
- W4387268308 cites W1670563716 @default.
- W4387268308 cites W1969887832 @default.
- W4387268308 cites W2008714478 @default.
- W4387268308 cites W2044726184 @default.
- W4387268308 cites W2060953488 @default.
- W4387268308 cites W2101982175 @default.
- W4387268308 cites W2165120552 @default.
- W4387268308 doi "https://doi.org/10.1111/jocd.15959" @default.
- W4387268308 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37782679" @default.
- W4387268308 hasPublicationYear "2023" @default.
- W4387268308 type Work @default.
- W4387268308 citedByCount "0" @default.
- W4387268308 crossrefType "journal-article" @default.
- W4387268308 hasAuthorship W4387268308A5002488034 @default.
- W4387268308 hasAuthorship W4387268308A5066020832 @default.
- W4387268308 hasAuthorship W4387268308A5072508737 @default.
- W4387268308 hasAuthorship W4387268308A5082184108 @default.
- W4387268308 hasBestOaLocation W43872683081 @default.
- W4387268308 hasConcept C104317684 @default.
- W4387268308 hasConcept C126322002 @default.
- W4387268308 hasConcept C12868164 @default.
- W4387268308 hasConcept C142724271 @default.
- W4387268308 hasConcept C16005928 @default.
- W4387268308 hasConcept C168563851 @default.
- W4387268308 hasConcept C185592680 @default.
- W4387268308 hasConcept C190119865 @default.
- W4387268308 hasConcept C204787440 @default.
- W4387268308 hasConcept C27081682 @default.
- W4387268308 hasConcept C2776677263 @default.
- W4387268308 hasConcept C2781121885 @default.
- W4387268308 hasConcept C55493867 @default.
- W4387268308 hasConcept C58226133 @default.
- W4387268308 hasConcept C65409693 @default.
- W4387268308 hasConcept C71924100 @default.
- W4387268308 hasConcept C90924648 @default.
- W4387268308 hasConceptScore W4387268308C104317684 @default.
- W4387268308 hasConceptScore W4387268308C126322002 @default.
- W4387268308 hasConceptScore W4387268308C12868164 @default.
- W4387268308 hasConceptScore W4387268308C142724271 @default.
- W4387268308 hasConceptScore W4387268308C16005928 @default.
- W4387268308 hasConceptScore W4387268308C168563851 @default.
- W4387268308 hasConceptScore W4387268308C185592680 @default.
- W4387268308 hasConceptScore W4387268308C190119865 @default.
- W4387268308 hasConceptScore W4387268308C204787440 @default.
- W4387268308 hasConceptScore W4387268308C27081682 @default.
- W4387268308 hasConceptScore W4387268308C2776677263 @default.
- W4387268308 hasConceptScore W4387268308C2781121885 @default.
- W4387268308 hasConceptScore W4387268308C55493867 @default.
- W4387268308 hasConceptScore W4387268308C58226133 @default.
- W4387268308 hasConceptScore W4387268308C65409693 @default.
- W4387268308 hasConceptScore W4387268308C71924100 @default.
- W4387268308 hasConceptScore W4387268308C90924648 @default.
- W4387268308 hasLocation W43872683081 @default.
- W4387268308 hasLocation W43872683082 @default.
- W4387268308 hasOpenAccess W4387268308 @default.
- W4387268308 hasPrimaryLocation W43872683081 @default.
- W4387268308 hasRelatedWork W2422131398 @default.
- W4387268308 hasRelatedWork W2745989082 @default.
- W4387268308 hasRelatedWork W2959730332 @default.
- W4387268308 hasRelatedWork W3000451357 @default.
- W4387268308 hasRelatedWork W3000588231 @default.
- W4387268308 hasRelatedWork W3168221830 @default.
- W4387268308 hasRelatedWork W4205769618 @default.
- W4387268308 hasRelatedWork W4318829708 @default.
- W4387268308 hasRelatedWork W4387268308 @default.
- W4387268308 hasRelatedWork W2507634944 @default.
- W4387268308 isParatext "false" @default.
- W4387268308 isRetracted "false" @default.
- W4387268308 workType "article" @default.